跳至主要内容
临床试验/JPRN-UMIN000009526
JPRN-UMIN000009526招募中2 期

Exploratory study to determine predictive factors of effectiveness of nab-paclitaxel in breast cancer (Expect study) - Exploratory study to determine predictive factors of effectiveness of nab-paclitaxel in breast cancer (Expect study)

Toho University School of Medicine, Medical Center, Ohashi Hospital0 个研究点目标入组 40 人开始时间: 2012年12月11日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.History of hypersensitivity reaction 2.HER2 positive confirmed by IHC or FISH 3. Active another cancer 4.Other severe complications, such as infection, diarrhea, intestinal tract paralysis, ileus, uncontrollable diabetes,uncontrollable angina, myocardial infarction within 6 months, heart failure, Pulmonary fibrosis or interstitial pneumonia, cerebrovascular disorder 5.With symptomatic brain cancer 6.With mental disorder which become problem on clinical practice 7.With serious bone marrow suppression, a renal damage, a liver damage 8.With serious pleural effusion or ascites 9.With infection or febrile infection 10. Hypersensitivity reaction of nab-paclitaxel or paclitaxel 11.During administration of flucytosine, phenytoin, warfarin potassium 8. Physician judged improper to entry this trial

研究者

发起方
Toho University School of Medicine, Medical Center, Ohashi Hospital

相似试验

Exploratory study to determine predictive factors of... | 临床试验